X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Piramal Healthcare with IPCA Labs - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PIRAMAL ENTERPRISES vs IPCA LABS - Comparison Results

PIRAMAL ENTERPRISES    Change

Piramal Enterprises has a presence in custom manufacturing, critical care OTC and financial services. To give a boost to its custom manufacturing operations, the company had acquired Avecia Pharmaceuticals, UK in 2005 and Pfizer's Morpeth facility in... More

IPCA LABS 
   Change

Ipca Laboratories is an integrated pharmaceutical company with presence in intermediates, APIs and formulations. The company has a strong focus on exports, catering to the US, Europe and the semi-regulated markets of the CIS, Africa and Asia. The com... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    PIRAMAL ENTERPRISES IPCA LABS PIRAMAL ENTERPRISES/
IPCA LABS
 
P/E (TTM) x 37.4 27.9 134.0% View Chart
P/BV x 3.7 2.1 174.1% View Chart
Dividend Yield % 0.7 0.2 271.6%  

Financials

 PIRAMAL ENTERPRISES   IPCA LABS
EQUITY SHARE DATA
    PIRAMAL ENTERPRISES
Mar-16
IPCA LABS
Mar-17
PIRAMAL ENTERPRISES/
IPCA LABS
5-Yr Chart
Click to enlarge
High Rs1,065643 165.6%   
Low Rs805503 160.1%   
Sales per share (Unadj.) Rs383.0254.4 150.6%  
Earnings per share (Unadj.) Rs55.116.1 342.8%  
Cash flow per share (Unadj.) Rs74.129.8 248.8%  
Dividends per share (Unadj.) Rs17.501.00 1,750.0%  
Dividend yield (eoy) %1.90.2 1,072.3%  
Book value per share (Unadj.) Rs719.9194.6 370.0%  
Shares outstanding (eoy) m172.56126.20 136.7%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x2.42.3 108.4%   
Avg P/E ratio x17.035.7 47.6%  
P/CF ratio (eoy) x12.619.2 65.6%  
Price / Book Value ratio x1.32.9 44.1%  
Dividend payout %31.86.2 510.5%   
Avg Mkt Cap Rs m161,34472,300 223.2%   
No. of employees `0003.813.3 28.4%   
Total wages/salary Rs m16,8986,960 242.8%   
Avg. sales/employee Rs Th17,472.62,413.5 724.0%   
Avg. wages/employee Rs Th4,466.9523.2 853.8%   
Avg. net profit/employee Rs Th2,512.8152.4 1,648.3%   
INCOME DATA
Net Sales Rs m66,09932,106 205.9%  
Other income Rs m2,425226 1,074.3%   
Total revenues Rs m68,52432,332 211.9%   
Gross profit Rs m18,7234,448 420.9%  
Depreciation Rs m3,2741,730 189.3%   
Interest Rs m9,388241 3,898.5%   
Profit before tax Rs m8,4852,703 313.9%   
Minority Interest Rs m30-   
Prior Period Items Rs m1,5930-   
Extraordinary Inc (Exp) Rs m4570-   
Tax Rs m1,032675 152.8%   
Profit after tax Rs m9,5062,028 468.7%  
Gross profit margin %28.313.9 204.5%  
Effective tax rate %12.225.0 48.7%   
Net profit margin %14.46.3 227.7%  
BALANCE SHEET DATA
Current assets Rs m47,48817,340 273.9%   
Current liabilities Rs m104,3629,559 1,091.7%   
Net working cap to sales %-86.024.2 -355.1%  
Current ratio x0.51.8 25.1%  
Inventory Days Days41100 40.5%  
Debtors Days Days5157 89.9%  
Net fixed assets Rs m26,53220,779 127.7%   
Share capital Rs m345252 136.7%   
"Free" reserves Rs m114,02424,499 465.4%   
Net worth Rs m124,22124,553 505.9%   
Long term debt Rs m75,8123,517 2,155.3%   
Total assets Rs m308,35639,595 778.8%  
Interest coverage x1.912.2 15.6%   
Debt to equity ratio x0.60.1 426.0%  
Sales to assets ratio x0.20.8 26.4%   
Return on assets %6.15.7 106.9%  
Return on equity %7.78.3 92.6%  
Return on capital %10.010.5 95.0%  
Exports to sales %17.248.6 35.3%   
Imports to sales %6.614.2 46.4%   
Exports (fob) Rs m11,36215,617 72.7%   
Imports (cif) Rs m4,3644,571 95.5%   
Fx inflow Rs m14,43515,617 92.4%   
Fx outflow Rs m5,1835,828 88.9%   
Net fx Rs m9,2539,790 94.5%   
CASH FLOW
From Operations Rs m-67,7732,764 -2,451.8%  
From Investments Rs m-8,768-1,432 612.4%  
From Financial Activity Rs m76,199-1,591 -4,788.5%  
Net Cashflow Rs m-342-259 132.3%  

Share Holding

Indian Promoters % 52.9 45.9 115.3%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 4.0 11.4 35.1%  
FIIs % 26.6 25.3 105.1%  
ADR/GDR % 0.0 0.0 -  
Free float % 16.5 17.4 94.8%  
Shareholders   93,274 36,892 252.8%  
Pledged promoter(s) holding % 0.0 2.1 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare PIRAMAL ENTERPRISES With:   CIPLA  SANOFI INDIA  ALEMBIC PHARMA  ALKEM LABORATORIES  DIVIS LABORATORIES  

Compare PIRAMAL ENTERPRISES With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Indian Indices Trade Marginally Higher; Pharma Sector Up 2.4%(11:30 am)

Stock markets in India are presently trading near the dotted line with positive bias. Sectoral indices are trading on a mixed note with stocks in the healthcare sector.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

This Small Cap Can Drive Chinese Players Out of India (and Make a Fortune in the Process)(The 5 Minute Wrapup)

Aug 17, 2017

A small-cap Indian company with high-return potential and blue-chip-like stability is set to supplant the Chinese players in this niche segment.

Dear PM Modi, India is Already Land of Self-Employed, and It Ain't Working(Vivek Kaul's Diary)

Aug 21, 2017

Most Indians who cannot find jobs, look at becoming self-employed.

It's the Best Time to Buy IT Stocks(Daily Profit Hunter)

Aug 16, 2017

The IT Sector could be in an uptrend till February 2019. Are you prepared to ride the trend?

5 Steps To Become Financially Independent(Outside View)

Aug 16, 2017

Ensure your financial Independence, and pledge to start the journey towards financial freedom today!

Think Twice Before You Keep Money In A Savings Bank Account(Outside View)

Aug 22, 2017

Post demonetisation, a cut in bank savings deposits rates was in the offing.

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

PIRAMAL ENTERPRISES SHARE PRICE


Aug 24, 2017 12:52 PM

TRACK PIRAMAL ENTERPRISES

  • Track your investment in PIRAMAL ENTERPRISES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON PIRAMAL ENTERPRISES

PIRAMAL ENTERPRISES 8-QTR ANALYSIS

COMPARE PIRAMAL ENTERPRISES WITH

MARKET STATS